Study Finds Ketogenic Diet May Offer Greater Metabolic Benefits Than Other Diets
Dietary changes are often a primary strategy for promoting healthy weight loss, as modifying food choices and overall calorie intake can help create a sustainable energy deficit. A recent study published in Cell Metabolism has shed light on the comparative effects of three popular dietary plans: the ketogenic (keto) diet, the Mediterranean diet, and a low-fat, plant-forward diet. The findings suggest that while all three diets can aid in weight loss, the ketogenic diet may offer distinct advantages for metabolic health, particularly for individuals with obesity, prediabetes, and fatty liver disease.
The study involved 42 participants who were randomly assigned to follow one of the three dietary plans. Each participant received food provisions and weekly meetings with a dietitian to support adherence. The goal was to achieve a weight loss of approximately 10% of their body weight, which took around four to five months. Lead author Max Petersen, MD, PhD, noted that moderate weight loss improved metabolic function across all diets, but the ketogenic diet produced several additional benefits beyond weight loss alone.
Participants on the ketogenic diet showed a remarkable average reduction of 67% in liver fat, compared to 45% reductions in both the Mediterranean and low-fat groups. Furthermore, those on the ketogenic diet experienced the greatest increase in glucagon, a hormone that helps regulate blood sugar and promotes fat breakdown in the liver. This was accompanied by a significant reduction in circulating insulin levels, which are typically elevated after carbohydrate consumption.
The researchers highlighted that the ketogenic diet's composition, characterized by low carbohydrate intake and higher fat content, may explain its superior effects on metabolic health. The study also revealed that about half of the participants in the ketogenic group no longer met the criteria for prediabetes after the weight-loss period, compared to 29% in the Mediterranean group and just 7% in the low-fat group.
Despite these promising results, the study's small sample size and short duration raise questions about the long-term sustainability and applicability of the ketogenic diet. Petersen cautioned that while the ketogenic diet may offer greater therapeutic benefits, maintaining such a diet can be challenging for many individuals due to its high fat content, which often includes saturated fats from animal products.
The findings contribute to the ongoing discussion about the role of diet composition in metabolic health, suggesting that the balance of carbohydrates, fats, and other nutrients may significantly influence outcomes beyond weight loss alone. As the landscape of obesity treatment evolves, particularly with the advent of medications targeting GLP-1 pathways, this study underscores the importance of considering dietary approaches alongside pharmacological options for managing metabolic health.




